According to a new report published by Allied Market Research, titled, “Gene Editing Market,” The gene editing market was valued at $3.9 billion in 2021, and is estimated to reach $7.4 billion by 2031, growing at a CAGR of 6.7% from 2022 to 2031.
♦ 𝐃𝐨𝐰𝐧𝐥𝐨𝐚𝐝 𝐅𝐫𝐞𝐞 𝐏𝐃𝐅 𝐁𝐫𝐨𝐜𝐡𝐮𝐫𝐞:
Key Findings of the Study –
• By technology, the crispr-cas9 gene editing segment has a global market share in 2021.
• Based on application, the gene editing segment has the highest market share in 2021 and is expected to remain dominant during the forecast period.
• By end user, the biotech sector and the pharmaceutical industry have the largest share of the market in 2021.
• The region, North America is expected to experience the highest growth rate, registering a CAGR of 6.6% during the forecast period.
On the basis of technology, the genetic analysis market is segmented into zinc finger, nucleases that act as catalysts, crispr-cas9 gene editing, restriction enzymes, etc. The rest are classified into homing endonucleases or mega nucleases and antisense technology. The crispr-cas9 gene editing segment led the market in 2021 with a revenue of $1,522.25 million and is expected to grow the gene editing industry at the highest CAGR by 7.9%. It is said that the growth of the organ is its application for drug discovery and identification of cancer.
Based on application, the gene editing market is segmented into gene editing, cell line engineering, animal cell engineering, plant gene engineering, drug development, etc. Other areas are divided into bioenergy, research, cell and gene therapy, genetic engineering of microorganisms, drug discovery, GMOs (genetically modified organisms), vaccine development and basic research. The gene editing segment led the market in 2021 with a revenue of $1,123.16 million and is expected to grow at the highest CAGR of 8.2%. The growth of the sector is attributed to the rise of clinical research and medical research.
♦ 𝐅𝐨𝐫 𝐏𝐮𝐫𝐜𝐡𝐚𝐬𝐞 𝐈𝐧𝐪𝐮𝐢𝐫𝐲 𝐨𝐟 𝐑𝐞𝐩𝐨𝐫𝐭:
By end user, the gene editing market is segmented into biotech and pharmaceutical industries, research institutes and governments, and contract research firms. The biotech and pharmaceutical industry segment lead the market in 2021 with a revenue of $2,311.49 million. In the gene editing market, the growth of the fastest growing segment is due to the increase in R&D expenditure for drug development and cancer treatment. The education and government sector are expected to grow at the highest CAGR of 7.2% during the forecast period.
Key Market Players –
Major key players that operate in the gene editing industry are Addgene, Allele Biotech, Bio-Rad Laboratories, CRISPR Therapeutics, General Electric, OriGene Technologies, Precision Biosciences, Takara Biotech, Thermofischer Scientific Inc., and Transposagen Biopharma Inc.
By Region –
North America (U.S., Canada, Mexico)
Europe (Germany, France, U.K., Italy, Spain, Rest of Europe)
LAMEA (Brazil, Saudi Arabia, South Africa, Rest of LAMEA)
Asia-Pacific (Japan, China, Australia, India, South Korea, Rest of Asia-Pacific)
♦ 𝐁𝐮𝐲 𝐍𝐨𝐰 𝐓𝐡𝐢𝐬 𝐄𝐱𝐜𝐥𝐮𝐬𝐢𝐯𝐞 𝐑𝐞𝐩𝐨𝐫𝐭:
Frequently Asked Questions?
Q1. What is the total market value of global gene editing market?
Q2. Which market holds the maximum market share of the global gene editing market?
Q3. What will be global gene editing market growth in 2030?
Q4. What are the key trends in the global gene editing market?
Q5. What are the key growth strategies of global gene editing market players
Q6. How the company profile has been selected?
About Us –
Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of “Market Research Reports” and “Business Intelligence Solutions.” AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.
Pawan Kumar, the CEO of Allied Market Research, is leading the organization toward providing high-quality data and insights. We are in professional corporate relations with various research data tables and confirms utmost accuracy in our market forecasting. Each and every us companies and this helps us in digging out market data that helps us generate accurate y data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.
5933 NE Win Sivers Drive
#205, Portland, OR 97220
USA/Canada (Toll Free): +1-800-792-5285, +1-503-894-6022
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060